semaglutide microneedle patch (DW-1022)
/ Raphas, Daewon Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 04, 2023
Korean pharma firms vie to develop patch-type obesity drugs
(Korea Biomedical Review)
- "...Daewoong Therapeutics, an affiliate of the Daewoong Group, plans to apply for an investigational new drug (IND) application for semaglutide-based obesity treatment in the form of a microneedle patch to the Ministry of Food and Drug Safety (MFDS) next year."
Non-US regulatory • Diabetes • Metabolic Disorders • Obesity
1 to 1
Of
1
Go to page
1